Indication
COVID-19 pneumonia
3 clinical trials
6 products
Clinical trial
A Pragmatic Adaptive Randomized, Controlled Phase II/III Multicenter Study of IFX-1 in Patients With Severe COVID-19 PneumoniaStatus: Completed, Estimated PCD: 2021-10-31
Product
BSCProduct
Placebo + SOCProduct
IFX-1 + BSCProduct
IFX-1Product
AstroStem-VClinical trial
A Phase I/Ⅱa Trial to Explore the Safety and Efficacy of Allogenic Adipose Tissue-derived Mesenchymal Stem Cell (AstroStem-V) Therapy in Patients With COVID-19 PneumoniaStatus: Recruiting, Estimated PCD: 2023-11-01
Clinical trial
Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, and Coronavirus Disease 2019 With [18F]FP-R01-MG-F2 With PET/CTStatus: Recruiting, Estimated PCD: 2025-04-14
Product
[18F]FP-R01-MG-F2